Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: Fort Worth TX, Mansfield TX, Garland TX, Tyler TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07415044
Phase 2, Recruiting
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
for
Fibrostenotic Crohn's Disease
Location: Fort Worth TX, Georgetown TX, Cedar Park TX,
Sponsor: Agomab Spain S.L.U.
Sex: All
Age: 18+
Code: NCT07683325
Phase 2, Recruiting
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
for
Liver Cirrhosis
Location: Fort Worth TX, Arlington TX, Dallas TX, Carrollton TX,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18 - 70+
Code: NCT07325526
Phase 2, Recruiting
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
for
Refractory Rheumatoid Arthritis (RA),
Location: Arlington TX, Irving TX, Red Oak TX, Mesquite TX,
Sponsor: Artiva Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06991114
Phase 2, Recruiting
New
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Arlington TX, Austin TX, San Antonio TX, Houston TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase 2, Phase 3, Recruiting
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
for
Complex Regional Pain Syndrome Type I
Location: Fort Worth TX, Mesquite TX, Houston TX, San Antonio TX,
Sponsor: Ambros Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07210515
Phase 3, Recruiting
New
A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a New AI Reading Tool; no New Interventions Will be Completed.
for
Small Bowel Bleeding
Location: Bedford TX, New York NY
Sponsor: AnX Robotica Corp.
Sex: All
Age: 22+
Code: NCT07633847
Recruiting
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)